• 011-26907444
  • raghava@iiitd.ac.in

Browse result page of AntiTbPdb

The total number entries retrieved from this search are 106
IDNameSequenceN-Terminal ModificationC-Terminal ModificationChemical ModificationLinear/CyclicLengthChiralityNatureSourceOriginSpeciesStrainInhibition ConcentrationIn vitro/ In vivoCell LineIntracellular InhibitionCytotoxicityAnimal ModelEffective Dose in model organismImmune ResponceMechanism of ActionTargetCombination TherapyOther ActivitiesYear of PublicationPubmed ID/ Patent No.
antitb_1970CM-II protein, Sarcotoxin IAGWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATARGFreeAmidationNoneLinear40LCationicNaturalNIH-Sape-4, an Embryonic Cell Line of Sarcophaga peregrinaMycobacterium smegmatisMycobacterium smegmatis ATCC607>100 μg/mlIn vitroNoneNoneNANA NoneNANAcell wall (lipid bilayer)NAStaphylococcus aureus FDA209P, Staphylococcus smith, Micrococcus luteus FDA16, Micrococcus luteus IF03333, Micrococcus luteus PC11001, Bacillus subtilis NRRI B-558, Bacillus subtilis PC1219, Corynebacterium bouis 1810, Corynebacterium michiganense, Xantbmonas oryzae, Pseudomonas lachrymans, Escherichia coli NIHJ, Shigella sonnei JS11746, Proteus vulgaris OX1919883182836
antitb_1971SapecinATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRNFreeFreeNoneLinear40LCationicNaturalNIH-Sape-4, an Embryonic Cell Line of Sarcophaga peregrinaMycobacterium smegmatisMycobacterium smegmatis ATCC60778 μg/mlIn vitroNoneNoneNANA NoneNANAcell wall (lipid bilayer)NAStaphylococcus aureus FDA209P, Staphylococcus smith, Micrococcus luteus FDA16, Micrococcus luteus IF03333, Micrococcus luteus PC11001, Bacillus subtilis NRRI B-558, Bacillus subtilis PC1219, Corynebacterium bouis 1810, Corynebacterium michiganense, Xantbmonas oryzae, Pseudomonas lachrymans, Escherichia coli NIHJ, Shigella sonnei JS11746, Proteus vulgaris OX1919883182836
antitb_1980Granulysin(1-35)GRDYRTSLTIVQKLKKMVDKPTQRSVSNAATRVSRFreeFreebutanedione (BAD) or citraconic anhydride(CAH)Linear35LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis25-40% Killing -25µMIn vitroNANANANA NANANAcell wallNA Escherichia coli200011120840
antitb_1981Granulysin(1-35)GRDYRTSLTIVQKLKKMVDKPTQRSVSNAATRVSRFreeFreebutanedione (BAD) or citraconic anhydride(CAH)Linear35LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis45-60% Killing -100 µMIn vitroNANANANA NANANAcell wallNA Escherichia coli200011120840
antitb_1982Granulysin(36-70)TGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQISFreeFreebutanedione (BAD) or citraconic anhydride(CAH)Linear35LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis25-40% Killing -25µMIn vitroNANANANA NANANAcell wallNA Escherichia coli200011120840
antitb_1983Granulysin(36-70)TGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQISFreeFreebutanedione (BAD) or citraconic anhydride(CAH)Linear35LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis45-60% Killing -100 µMIn vitroNANANANA NANANAcell wallNA Escherichia coli200011120840